Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

NCT00562965 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Lymphoma, Follicular

Interventions

DRUG: inotuzumab ozogamicin
DRUG: rituximab
DRUG: rituximab
DRUG: cyclophosphamide
DRUG: vincristine
DRUG: prednisone/prednisolone
DRUG: mitoxantrone
DRUG: fludarabine
DRUG: dexamethasone

Sponsor

Pfizer

Collaborators

[object Object]